Analyst Research

Report Title Price
Thomson Reuters Stock Report - ROHTO PHARMACEUTICAL CO., LTD. (4527-TO)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Wright Investors Service Comprehensive Report for Rohto Pharmaceutical Co., Ltd.
Provider: Wright Reports
$460.00
Buy
Rohto Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Rohto Pharmaceutical Co., Ltd. (4527) - Financial Analysis Review
Provider: GlobalData
$125.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

ROHTO PHARMACEUTICAL CO LTD Establishes Joint Venture in Thailand with ASIA HERB ASSOCIATION CO., LTD.


Thursday, 7 Feb 2013 01:10am EST 

ROHTO PHARMACEUTICAL CO LTD announced that it has established a joint venture ROHTO ASIA HERB (THAILAND) CO.,LTD., which will be engaged in the spa and resort business and organic herb business in Thailand, with ASIA HERB ASSOCIATION CO., LTD. on January 31, 2013. The Company and ASIA HERB ASSOCIATION will hold a 40% stake and a 60% stake in the joint venture, respectively. 

Latest Developments for Rohto Pharmaceutical Co Ltd

Latest Key Developments in Personal

Company Quote

Rohto Pharmaceutical Co Ltd
(4527.OS)
1510.0
72.0 +5.01%
17 May 2013